Partners Group reported a 13% decline in first-half 2026 profit to CHF 502 million, driven by a 39% drop in performance income despite a 6% rise in management income. Revenue fell 7% to CHF 1.12 billion, affected by weaker performance income and currency impacts. The firm confirmed its full-year fundraising target of $26-32 billion but lowered near-term performance income expectations. Leadership changes include CEO David Layton moving to CIO and Chairman roles, with Roberto Cagnati and Juri Jenkner named Co-CEOs starting January 2027. The results highlight resilience in management fees but challenges in timing investment exits and currency effects.
Bunzl PLC reported stronger-than-expected financial results with an EPS of $0.60, surpassing the $0.56 consensus. Revenue reached $8.04 billion, driven by a 3.2% underlying growth, especially in North America. The operating margin improved to 7.3%, p...
Palo Alto Networks is set to report strong earnings per share (EPS) of $0.98 and revenue of $3.35 billion for the upcoming quarter, reflecting significant growth from last year. Investor optimism is driven by robust cybersecurity sector trends and a ...
Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised it...
Dell Technologies is expected to report record second-quarter earnings with EPS around $4.91 and revenue near $44.89 billion, fueled by high demand for its AI-optimized servers. This would mark a significant increase from last year's $29.78 billion a...
Protagonist Therapeutics saw its stock price target raised to $180 by Barclays following the FDA approval of MIMRYLO, a first-in-class drug for polycythemia vera. The approval was based on strong Phase 3 trial results with 76.9% patient response, tri...
